Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Baricitinib is effective and safe for treating severe alopecia areata.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Hair absorbs different substances from solutions based on pH levels.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Corin helps control salt and sweat release in sweat glands.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Stress turns hair white by depleting color-giving cells in hair follicles through a specific neurotransmitter related to the body's stress response.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

AB+ blood group is more common in alopecia areata patients.